Neuroendocrine Tumors of the Pancreas Grade 2 with Ki-67 Index More Than 5% and with Expression Cytokeratin 19 are the Risk Group of Rapid Progression

被引：0
|
作者：
Gurevich, L. [1 ]
Korsakova, N. [2 ]
Kazantseva, I. [2 ]
Egorov, A. [3 ]
Britvin, T. [2 ]
Vasilev, I [3 ]
机构：
[1] MF Vladimirsky Moscow Reg Res Clin Inst, Moscow, Russia
[2] Vladimirsky Moscow Reg Res Clin Inst, Moscow, Russia
[3] Moscow State Med Univ, Moscow, Russia
来源：
NEUROENDOCRINOLOGY | 2014年 / 99卷 / 3-4期
关键词：
pancreas; neuroendocrine tumors; risk factors; ki-67; cytokeratin; 19;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
G9
引用
收藏
页码：247 / 247
页数：1
相关论文
共 50 条
  • [31] O6-MethylGuanine DNA MethylTransferase (MGMT) expression and Ki-67 index predict response to temozolomide in patients with Well Differentiated Pancreatic NeuroEndocrine Tumors (WDPNET)
    Cros, J.
    Hentic, O.
    Rebours, V.
    Zappa, M.
    Maire, F.
    Hammel, P.
    Levy, P.
    Ruszniewski, P.
    Couvelard, A.
    VIRCHOWS ARCHIV, 2013, 463 (02) : 289 - 289
  • [32] Is proliferative index (Ki-67) useful to stratify patients (pts) with G2 gastroenteropancreatic neuroendocrine tumors (GEP-NETs)? Clinicopathologic correlation.
    Angel, Martin
    Connor, Juan O.
    Pesce, Veronica
    Ariel Mendez, Guillermo
    Bestani, Claudia
    Marmissolle, Fabiana
    Giacomi, Nora
    Belli, Susana
    Domenichini, Enzo
    Chacon, Matias
    Zamora, Victor
    Maria Cabanne, Ana
    Parma, Patricia
    Luis Roca, Enrique
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (03)
  • [33] Predictive value of preoperative MRI features for the Ki-67 index in well-differentiated G1/G2 pancreatic neuroendocrine tumors
    Sun, Haitao
    Zhang, Shilong
    Liu, Kai
    Zhou, Jianjun
    Wang, Xingxing
    Shen, Tingting
    Wang, Xiaolin
    ACTA RADIOLOGICA, 2019, 60 (11) : 1394 - 1404
  • [34] Impact of FDG PET/CT Scan in Changing Management of Well-Differentiated Neuroendocrine Tumors With Ki67 Index Less Than or Equal to 5%
    Choudhury, Sayak
    Agrawal, Archi
    Rangarajan, Venkatesh
    Puranik, Ameya
    Bal, Munita
    Chaudhari, Vikram
    Bhandare, Manish
    Purandare, Nilendu
    Shah, Sneha
    Ramaswamy, Anant
    Ostwal, Vikas
    Shrikhande, Shailesh, V
    CLINICAL NUCLEAR MEDICINE, 2022, 47 (11) : E676 - E681
  • [35] Thymus neuroendocrine tumors with CTNNB1 gene mutations, disarrayed ß-catenin expression, and dual intra-tumor Ki-67 labeling index compartmentalization challenge the concept of secondary high-grade neuroendocrine tumor: a paradigm shift
    Alessandra Fabbri
    Mara Cossa
    Angelica Sonzogni
    Paolo Bidoli
    Stefania Canova
    Diego Cortinovis
    Maria Ida Abbate
    Fiorella Calabrese
    Nazarena Nannini
    Francesca Lunardi
    Giulio Rossi
    Stefano La Rosa
    Carlo Capella
    Elena Tamborini
    Federica Perrone
    Adele Busico
    Iolanda Capone
    Barbara Valeri
    Ugo Pastorino
    Adriana Albini
    Giuseppe Pelosi
    Virchows Archiv, 2017, 471 : 31 - 47
  • [36] Thymus neuroendocrine tumors with CTNNB1 gene mutations, disarrayed -catenin expression, and dual intra-tumor Ki-67 labeling index compartmentalization challenge the concept of secondary high-grade neuroendocrine tumor: a paradigm shift
    Fabbri, Alessandra
    Cossa, Mara
    Sonzogni, Angelica
    Bidoli, Paolo
    Canova, Stefania
    Cortinovis, Diego
    Abbate, Maria Ida
    Calabrese, Fiorella
    Nannini, Nazarena
    Lunardi, Francesca
    Rossi, Giulio
    La Rosa, Stefano
    Capella, Carlo
    Tamborini, Elena
    Perrone, Federica
    Busico, Adele
    Capone, Iolanda
    Valeri, Barbara
    Pastorino, Ugo
    Albini, Adriana
    Pelosi, Giuseppe
    VIRCHOWS ARCHIV, 2017, 471 (01) : 31 - 47
  • [37] Clinical and biological heterogeneity of Grade 2 digestive neuroendocrine neoplasms: prognostic significance of the 10% Ki-67 index cutoff and implications for treatment strategies. A longitudinal study
    Massironi, Sara
    Gallo, Camilla
    Coltro, Lorenzo
    Dell'Anna, Giuseppe
    Preatoni, Paoletta
    Danese, Silvio
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2025,
  • [38] Reappraisal of the Utility of Mitosis, Ki67 Index, and SSTR2 Expression in the Differential Diagnosis between Grade 3 Well-differentiated Neuroendocrine Tumor and Poorly Differentiated Neuroendocrine Carcinoma of the Gastrointestinal Tract and Pancreas
    Sweeney, Jacob
    Yang, Zhaohai
    MODERN PATHOLOGY, 2021, 34 (SUPPL 2) : 478 - 479
  • [39] Reappraisal of the Utility of Mitosis, Ki67 Index, and SSTR2 Expression in the Differential Diagnosis between Grade 3 Well-differentiated Neuroendocrine Tumor and Poorly Differentiated Neuroendocrine Carcinoma of the Gastrointestinal Tract and Pancreas
    Sweeney, Jacob
    Yang, Zhaohai
    LABORATORY INVESTIGATION, 2021, 101 (SUPPL 1) : 478 - 479
  • [40] O6-Methylguanine DNA Methyltransferase (MGMT) Expression and Ki-67 Index Predict Response to Temozolomide in Patients with Well-Differentiated Pancreatic Neuroendocrine Tumors (WDPNET)
    Cros, J.
    Hentic, O.
    Rebours, V
    Zappa, M.
    Maire, F.
    Hammel, P.
    Levy, P.
    Ruszniewski, P.
    Couvelard, A.
    NEUROENDOCRINOLOGY, 2014, 99 (3-4) : 254 - 254
12345